Otezla 30 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F7VM8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,803
Award facts
- Contract value 100% obligated
- $25,803.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $25.8K delivery order to AmerisourceBergen Drug Corp (parent company: Cencora, Inc.) on January 29, 2026, for the supply of Otezla 30 mg tablets (60-count units). This competitively awarded, firm fixed-price contract carries no set-aside designation and is scheduled for completion by January 30, 2026. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is executed under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at up to $999.999 billion through December 2026), which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen, as a major pharmaceutical distributor and critical federal medical procurement vendor, regularly supplies brand-name and generic medications across multiple therapeutic domains to military treatment facilities and other federal healthcare systems. The Otezla order supports the Defense Logistics Agency's mission to provision essential pharmaceutical products to Department of Defense healthcare operations. Through its established IDC framework, AmerisourceBergen demonstrates the operational capability and competitive standing necessary to fulfill federal medical supply requirements efficiently and at firm fixed pricing across a diverse portfolio of prescription medications and medical commodities.
Quick answers
Who was awarded contract SPE2DR26F7VM8?
SPE2DR26F7VM8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26F7VM8 worth?
The government has obligated $25,803 on SPE2DR26F7VM8.
Is contract SPE2DR26F7VM8 an order under another contract?
Yes. SPE2DR26F7VM8 is a delivery order under SPE2DR25D2216, an indefinite delivery contract.
Was contract SPE2DR26F7VM8 competed?
The extent of competition for SPE2DR26F7VM8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award